Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Pruritus”

64 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 64 results

Large-scale testing (Phase 3)Study completedNCT03066609
What this trial is testing

Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 543
Testing effectiveness (Phase 2)Study completedNCT02871011
What this trial is testing

Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's Foot

Who this might be right for
Tinea Pedis
Nitric Solutions Inc. 20
Post-approval studies (Phase 4)WithdrawnNCT03146247
What this trial is testing

Analysis of the Pathogenesis of Itch in Response to Apremilast Therapy in Psoriasis Patients

Who this might be right for
Moderate to Severe Plaque Psoriasis
Diamant Thaci
Early research (Phase 1)UnknownNCT04317209
What this trial is testing

SHR0410 in Hemodialysis Patients With Pruritus

Who this might be right for
Pruritus
Jiangsu HengRui Medicine Co., Ltd. 54
Large-scale testing (Phase 3)Study completedNCT03422653
What this trial is testing

Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1)

Who this might be right for
Uremic Pruritus
Cara Therapeutics, Inc. 378
Testing effectiveness (Phase 2)Study completedNCT03617536
What this trial is testing

Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Who this might be right for
Chronic Kidney DiseasesPruritus
Cara Therapeutics, Inc. 269
Testing effectiveness (Phase 2)Ended earlyNCT03995212
What this trial is testing

Study to Evaluate the Safety and Efficacy of Oral CR845 (Difelikefalin) in Patients With Primary Biliary Cholangitis (PBC) and Moderate-to-Severe Pruritus

Who this might be right for
Cholestatic Pruritus
Cara Therapeutics, Inc. 14
Testing effectiveness (Phase 2)Ended earlyNCT04605094
What this trial is testing

Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AstraZeneca 194
Large-scale testing (Phase 3)Looking for participantsNCT06979453
What this trial is testing

Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Bristol-Myers Squibb 366
Large-scale testing (Phase 3)Study completedNCT01815424
What this trial is testing

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 266
Testing effectiveness (Phase 2)Study completedNCT04365387
What this trial is testing

Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab

Who this might be right for
Dermatitis, Atopic
Galderma R&D 242
Large-scale testing (Phase 3)Study completedNCT01276639
What this trial is testing

A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 901
Large-scale testing (Phase 3)Study completedNCT03636269
What this trial is testing

CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

Who this might be right for
Uremic Pruritus
Cara Therapeutics, Inc. 473
Testing effectiveness (Phase 2)Ended earlyNCT03517566
What this trial is testing

Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 293
Large-scale testing (Phase 3)Study completedNCT02474069
What this trial is testing

Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 772
Not applicableLooking for participantsNCT07056660
What this trial is testing

Atmospheric Pressure Cold Plasma for Moderate-to-severe Tinea Pedis

Who this might be right for
Tinea Pedis
Shenyang Medical College 220
Testing effectiveness (Phase 2)Study completedNCT02424253
What this trial is testing

Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Ziarco Pharma Ltd 98
Large-scale testing (Phase 3)Study completedNCT05885737
What this trial is testing

Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus

Who this might be right for
Uremic Pruritus
Vifor Fresenius Medical Care Renal Pharma 260
Testing effectiveness (Phase 2)Study completedNCT03858634
What this trial is testing

Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

Who this might be right for
Chronic Idiopathic UrticariaChronic Idiopathic PruritusLichen Planus+2 more
Genentech, Inc. 58
Large-scale testing (Phase 3)Study completedNCT02858726
What this trial is testing

Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

Who this might be right for
Uremic Pruritus
Cara Therapeutics, Inc. 226
Load More Results